John T. Henderson - Dec 11, 2024 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role
Director
Signature
/s/ Robert Wong, attorney-in-fact for Dr. Henderson
Stock symbol
CYTK
Transactions as of
Dec 11, 2024
Transactions value $
-$2,251
Form type
4
Date filed
12/12/2024, 04:05 PM
Previous filing
Oct 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Options Exercise $13.1K +1.78K +4.63% $7.37 40.2K Dec 11, 2024 Direct
transaction CYTK Common Stock Sale -$89.7K -1.78K -4.42% $50.42 38.5K Dec 11, 2024 Direct
transaction CYTK Common Stock Options Exercise $74.4K +10.1K +26.24% $7.37 48.6K Dec 11, 2024 Direct
holding CYTK Common Stock 83 Dec 11, 2024 by Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -1.78K -14.99% $0.00 10.1K Dec 11, 2024 Common Stock 1.78K $7.37 Direct
transaction CYTK Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -10.1K -100% $0.00 0 Dec 11, 2024 Common Stock 10.1K $7.37 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).